• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者严重感染风险评分的开发与验证

Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.

作者信息

Crowson Cynthia S, Hoganson Deana D, Fitz-Gibbon Patrick D, Matteson Eric L

机构信息

Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Arthritis Rheum. 2012 Sep;64(9):2847-55. doi: 10.1002/art.34530.

DOI:10.1002/art.34530
PMID:22576809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3424339/
Abstract

OBJECTIVE

Infection risk is increased in patients with rheumatoid arthritis (RA), and accurate assessment of the risk of infection could inform clinical decision-making. This study was undertaken to develop and validate a score to predict the 1-year risk of serious infection in patients with RA.

METHODS

We studied a population-based cohort of Olmsted County, Minnesota residents with incident RA ascertained in 1955-1994 whose members were followed up longitudinally, via complete medical records, until January 2000. The validation cohort included residents with incident RA ascertained in 1995-2007. The outcome measure included all serious infections (requiring hospitalization or intravenous antibiotics). Potential predictors were examined using multivariable Cox models. The risk score was estimated directly from the multivariable model, and performance was assessed in the validation cohort using Harrell's C statistic.

RESULTS

Among the 584 RA patients in the original cohort (72% female; mean age 57.5 years), who were followed up for a median of 9.9 years, 252 had ≥ 1 serious infection (646 total infections). Components of the risk score included age, previous serious infection, corticosteroid use, elevated erythrocyte sedimentation rate, extraarticular manifestations of RA, and comorbidities (coronary heart disease, heart failure, peripheral vascular disease, chronic lung disease, diabetes mellitus, alcoholism). Validation analysis revealed good discrimination (C statistic 0.80).

CONCLUSION

RA disease characteristics and comorbidities can be used to accurately assess the risk of serious infection in patients with RA. Knowledge of risk of serious infection in RA patients can influence clinical decision making and inform strategies to reduce and prevent the occurrence of these infections.

摘要

目的

类风湿关节炎(RA)患者的感染风险增加,准确评估感染风险可为临床决策提供依据。本研究旨在开发并验证一个用于预测RA患者1年严重感染风险的评分系统。

方法

我们研究了明尼苏达州奥姆斯特德县基于人群的队列,这些居民在1955 - 1994年确诊为新发RA,通过完整的医疗记录对其进行纵向随访,直至2000年1月。验证队列包括在1995 - 2007年确诊为新发RA的居民。结局指标包括所有严重感染(需要住院或静脉使用抗生素)。使用多变量Cox模型检查潜在预测因素。风险评分直接从多变量模型中估计,并在验证队列中使用Harrell's C统计量评估其性能。

结果

在原始队列的584例RA患者中(72%为女性;平均年龄57.5岁),随访时间中位数为9.9年,252例发生了≥1次严重感染(共646次感染)。风险评分的组成部分包括年龄、既往严重感染、使用皮质类固醇、红细胞沉降率升高、RA的关节外表现以及合并症(冠心病、心力衰竭、外周血管疾病、慢性肺病、糖尿病、酗酒)。验证分析显示具有良好的区分度(C统计量为0.80)。

结论

RA的疾病特征和合并症可用于准确评估RA患者发生严重感染的风险。了解RA患者严重感染的风险可影响临床决策,并为减少和预防这些感染的发生提供策略依据。

相似文献

1
Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.类风湿关节炎患者严重感染风险评分的开发与验证
Arthritis Rheum. 2012 Sep;64(9):2847-55. doi: 10.1002/art.34530.
2
Predictors of infection in rheumatoid arthritis.类风湿关节炎感染的预测因素。
Arthritis Rheum. 2002 Sep;46(9):2294-300. doi: 10.1002/art.10529.
3
Cardiovascular death in rheumatoid arthritis: a population-based study.类风湿关节炎患者的心血管死亡:一项基于人群的研究。
Arthritis Rheum. 2005 Mar;52(3):722-32. doi: 10.1002/art.20878.
4
Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.1995-2007 年与 1985-1994 年明尼苏达州奥姆斯特德县类风湿关节炎关节外发病率:一项基于人群的研究。
J Rheumatol. 2011 Jun;38(6):983-9. doi: 10.3899/jrheum.101133. Epub 2011 Apr 1.
5
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.1557 例类风湿关节炎患者队列中严重感染的 RABBIT 评分的发生率、风险因素和验证。
Rheumatology (Oxford). 2021 May 14;60(5):2223-2230. doi: 10.1093/rheumatology/keaa557.
6
Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.影响改善病情抗风湿药物停用的患者、疾病及治疗相关因素:一项基于人群的类风湿关节炎患者发病队列研究
J Rheumatol. 2006 Feb;33(2):248-55. Epub 2005 Dec 15.
7
Trends in serious infections in rheumatoid arthritis.类风湿关节炎严重感染的趋势。
J Rheumatol. 2013 May;40(5):611-6. doi: 10.3899/jrheum.121075. Epub 2013 Apr 1.
8
The influence of rheumatoid arthritis disease characteristics on heart failure.类风湿关节炎疾病特征对心力衰竭的影响。
J Rheumatol. 2011 Aug;38(8):1601-6. doi: 10.3899/jrheum.100979. Epub 2011 May 15.
9
Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model.生物药物治疗关节炎患者的严重感染风险:一项匹配队列研究和预测模型的建立。
Rheumatology (Oxford). 2021 Aug 2;60(8):3834-3844. doi: 10.1093/rheumatology/keaa876.
10
Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.抗肿瘤坏死因子治疗的类风湿关节炎患者严重感染 5 年风险的预测因素:荷兰类风湿关节炎监测(DREAM)登记处的队列研究。
Rheumatology (Oxford). 2013 Jun;52(6):1052-7. doi: 10.1093/rheumatology/kes413. Epub 2013 Jan 30.

引用本文的文献

1
Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis.血清阳性及改善病情抗风湿药物对类风湿关节炎患者患肺结核风险的影响。
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00957-2024. eCollection 2025 May.
2
Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.日本使用托珠单抗治疗的类风湿关节炎患者严重感染预测模型的开发与验证
Clin Rheumatol. 2025 Mar;44(3):1081-1093. doi: 10.1007/s10067-025-07328-9. Epub 2025 Feb 7.
3
Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?老年类风湿关节炎患者应用小剂量糖皮质激素:证据说了什么?
Drugs Aging. 2024 Aug;41(8):641-652. doi: 10.1007/s40266-024-01133-w. Epub 2024 Jul 27.
4
Incidence Rates of Infections in Rheumatoid Arthritis Patients Treated with Janus Kinase or Interleukin-6 Inhibitors: Results of a Retrospective, Multicenter Cohort Study.接受Janus激酶或白细胞介素-6抑制剂治疗的类风湿关节炎患者的感染发生率:一项回顾性多中心队列研究的结果
J Clin Med. 2024 May 20;13(10):3000. doi: 10.3390/jcm13103000.
5
Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study.类风湿关节炎相关间质性肺疾病患者队列中严重和致命感染的发生率:一项多中心前瞻性研究。
Front Immunol. 2024 Mar 28;15:1341321. doi: 10.3389/fimmu.2024.1341321. eCollection 2024.
6
Management of Scleritis in Older Adults.老年巩膜炎的治疗。
Drugs Aging. 2024 Apr;41(4):287-302. doi: 10.1007/s40266-024-01105-0. Epub 2024 Mar 5.
7
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis.类风湿关节炎患者的多种合并症与严重感染相关。
Semin Arthritis Rheum. 2024 Apr;65:152386. doi: 10.1016/j.semarthrit.2024.152386. Epub 2024 Jan 15.
8
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a analysis of ORAL Surveillance.接受托法替布或肿瘤坏死因子抑制剂治疗的类风湿性关节炎患者的疾病活动度及不良事件:ORAL监测分析
Ther Adv Musculoskelet Dis. 2023 Nov 6;15:1759720X231201047. doi: 10.1177/1759720X231201047. eCollection 2023.
9
Aetiologies of Acute Complications in Autoimmune Rheumatologic Diseases: A Hospital-Based Cross-Sectional Study.自身免疫性风湿性疾病急性并发症的病因:一项基于医院的横断面研究。
Cureus. 2023 Mar 8;15(3):e35916. doi: 10.7759/cureus.35916. eCollection 2023 Mar.
10
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.五种不同的新型冠状病毒2疫苗在病情缓解或疾病活动度低的自身免疫性风湿和肌肉骨骼疾病患者及健康对照中的体液和细胞免疫原性及安全性:一项单中心研究
Front Immunol. 2022 Mar 31;13:846248. doi: 10.3389/fimmu.2022.846248. eCollection 2022.

本文引用的文献

1
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.肿瘤坏死因子-α拮抗剂的起始治疗与自身免疫性疾病患者感染住院风险。
JAMA. 2011 Dec 7;306(21):2331-9. doi: 10.1001/jama.2011.1692. Epub 2011 Nov 6.
2
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?治疗获益还是适者生存:是什么导致 TNF 抑制下严重感染率的时间依赖性下降,这对个体患者意味着什么?
Ann Rheum Dis. 2011 Nov;70(11):1914-20. doi: 10.1136/ard.2011.151043. Epub 2011 Jul 25.
3
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.类风湿关节炎患者发生脓毒性关节炎的风险和抗 TNF 治疗的效果:来自英国风湿病学会生物制剂注册处的结果。
Ann Rheum Dis. 2011 Oct;70(10):1810-4. doi: 10.1136/ard.2011.152769. Epub 2011 Jul 21.
4
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents.类风湿关节炎患者起始或转换生物制剂治疗后的严重感染风险比较。
Ann Rheum Dis. 2011 Aug;70(8):1401-6. doi: 10.1136/ard.2010.146365. Epub 2011 May 17.
5
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis.高疾病活动度与类风湿关节炎患者的感染风险增加有关。
Ann Rheum Dis. 2011 May;70(5):785-91. doi: 10.1136/ard.2010.128637. Epub 2011 Feb 2.
6
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.抗 TNF 治疗与类风湿关节炎患者严重感染的风险增加相关,尤其是在治疗的前 6 个月:英国风湿病学会生物制剂注册处的最新结果,特别强调了老年人的风险。
Rheumatology (Oxford). 2011 Jan;50(1):124-31. doi: 10.1093/rheumatology/keq242. Epub 2010 Jul 31.
7
Assessing the performance of prediction models: a framework for traditional and novel measures.评估预测模型的性能:传统和新型指标的框架。
Epidemiology. 2010 Jan;21(1):128-38. doi: 10.1097/EDE.0b013e3181c30fb2.
8
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality.类风湿关节炎中的系统性红斑狼疮特征及其对总体死亡率的影响。
J Rheumatol. 2009 Jan;36(1):50-7. doi: 10.3899/jrheum.080091.
9
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.类风湿关节炎患者使用非生物改善病情抗风湿药与感染风险
Arthritis Rheum. 2008 Aug 15;59(8):1074-81. doi: 10.1002/art.23913.
10
The risk of hospitalized infection in patients with rheumatoid arthritis.类风湿关节炎患者发生医院感染的风险。
J Rheumatol. 2008 Mar;35(3):387-93. Epub 2008 Feb 1.